DUBLIN--(BUSINESS WIRE)--Jul 6, 2018--The "Occlusion Devices Market by Product (Occlusion Balloon, Stent Retriever, Suction Device, Coil Embolization, Liquid Embolics), Application (Cardiology, Neurology, Peripheral Vascular, Urology, Oncology, Gyno), End User - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering. The global occlusion devices market is projected to reach USD 3.55 Billion by 2023 from USD 2.74 Billion in 2018, at a CAGR of 5.3%. This report broadly segments the occlusion devices market into product, application, end user, and region. On the basis of product, in 2018, the occlusion removal devices segment is expected to account for the largest share of the market. This can be attributed to the increasing research activity to validate the clinical efficacy of novel occlusion removal devices (such as stent retrievers, coil retrievers, and balloon occlusion devices) and growing patient preference for minimally invasive surgeries. Based on application, the neurology applications segment accounted for the largest share of the market in 2017. The increasing number of target neurosurgical procedures across major countries, growing research in the field of interventional neurology, strengthening research capabilities of major product manufacturers, and favorable reimbursement scenario for neurovascular surgeries across developed countries are the key factors supporting the growth of the occlusion devices market for neurology applications. Based on end-user, in 2018, the hospitals, diagnostic centers, and surgical centers segment is expected to account for the largest share of the market due to the growing adoption of minimally invasive surgical procedures, increasing purchasing power of major end users across developed countries, and the availability of reimbursements for target procedures in the US and major European countries. Market Dynamics Drivers

Expansion of Target Patient Population Base Technological Advancements Favorable Reimbursement Scenario for Minimally Invasive Surgeries Rising Number of Minimally Invasive Vascular Surgeries Focus on Expansion of Manufacturing & Distribution Capabilities in Emerging Markets Clinical Evidence for Safety and Efficacy of Occlusion Devices

Restraints

Procedural Limitations Associated With CTO Treatment Stringent Regulatory Framework for Product Commercialization

Opportunities

Rising Healthcare Expenditure Across Developing Countries

Challenge

Dearth of Skilled Surgeons

Key Topics Covered 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Occlusion Devices Market, By Product 7 Occlusion Devices Market, By Application 8 Occlusion Devices Market, By End-User 9 Occlusion Devices Market, By Region 10 Competitive Landscape 11 Company Profiles

Abbott Laboratories Acrostak Angiodynamics Asahi Intecc Avinger Boston Scientific B. Braun Cardinal Health Cook Group C.R. Bard (A Part of Becton Dickinson) Edwards Lifesciences Medtronic Penumbra Stryker Corporation Terumo Corporation

For more information about this report visit https://www.researchandmarkets.com/research/5gsr2j/occlusion?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180706005184/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Medical Devices

KEYWORD:

INDUSTRY KEYWORD: HEALTH CARDIOLOGY MEDICAL DEVICES

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 07/06/2018 08:29 AM/DISC: 07/06/2018 08:29 AM

http://www.businesswire.com/news/home/20180706005184/en